节点文献
中国老年骨质疏松症诊疗指南(2018)
2018 China guideline for diagnosis and treatment of senile osteoporosis
【摘要】 根据国内外循证医学指南制定标准化方法与步骤,组建多学科指南制定专家工作组,先后经过指南注册及指南计划书撰写、相关指南评价分析、临床问题遴选和确定、临床证据检索及评价、形成推荐意见等流程,经共识专家组3轮讨论,最终制定中国老年骨质疏松症诊疗指南(2018)。使用GRADE系统对证据体和推荐意见进行分级。同时考虑中国患者的偏好与价值观、干预措施的成本和利弊平衡为老年骨质疏松症的诊疗提供15条推荐意见。该指南涵盖了老年骨质疏松症的筛查、风险评估、诊断、基础措施、多种抗骨质疏松药物、疗效监测和评估等方面。本指南旨在为我国广大临床医生和患者提供科学依据。
【Abstract】 According to the standard method and procedures for the development of evidence-based medicine guidelines, a multi-disciplinary guideline development working group was established. Through the process of guideline registration, guideline plan writing, analysis of relevant guidelines, clinical problem screening and determination, clinical evidence retrieval and evaluation, forming of recommendation, etc. and after three rounds of discussions by the consensus expert group, a new evidence-based guideline for diagnosis and treatment of senile osteoporosis in China(2018) was developed. The grading of recommendations assessment, development and evaluation(GRADE) system was used to rate the quality of evidence and the strength of recommendations. Recommendations were derived from body of evidence, and at the same time considered the balance of benefits and harms as well as values and preferences of Chinese patients. The guideline development working group developed 15 recommendations for the diagnosis and treatment of senile osteoporosis. The guideline covered the screening for senile osteoporosis, risk assessment, diagnosis, basic treatment, multiple anti-osteoporosis drugs, therapeutic effect monitoring and evaluation of senile osteoporosis. This guideline aims to provide scientific evidence for clinicians and patients in China.
- 【文献出处】 中国骨质疏松杂志 ,Chinese Journal of Osteoporosis , 编辑部邮箱 ,2018年12期
- 【分类号】R580
- 【被引频次】414
- 【下载频次】8260